Alaska Creates Task Force for the Regulation of FDA Approved Psychedelic Medicines

October 4, 2024

Pain Management/Prescribing Practices

Alaska HB 228  Enacted September 19 and effective immediately, establishes the Task Force for the Regulation of FDA Approved Psychedelic Medicines to “prepare for the potential medicalization of psychedelic medicines… make policy recommendations to the Legislature concerning insurance and licensure… and to ensure the state is prepared if psychedelic medicines become available for prescription” as well as provide rules about the task force’s membership, selection process, the schedule and timeline for the report, and its eventual termination.